THE EARLY EFFECTS OF RADIOIODINE THERAPY FOR HYPERTHYROIDISM ON BIOCHEMICAL INDEXES OF BONE TURNOVER

被引:35
作者
MACLEOD, JM
MCHARDY, KC
HARVEY, RD
DUNCAN, A
REID, IW
BEWSHER, PD
ROBINS, SP
机构
[1] UNIV ABERDEEN, DEPT MED & THERAPEUT, POLWARTH BLDG, ABERDEEN AB9 2ZD, SCOTLAND
[2] UNIV ABERDEEN, DEPT CLIN BIOCHEM, ABERDEEN AB9 2ZD, SCOTLAND
[3] ROWETT RES INST, BUCKSBURN AB2 9SB, ABERDEEN, SCOTLAND
关键词
D O I
10.1111/j.1365-2265.1993.tb00972.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE We investigated the early changes following radioiodine therapy for hyperthyroidism, in biochemical indices of bone synthesis and degradation, and their relationship to circulating thyroid hormone concentrations. DESIGN Prospective follow-up over the first 12 weeks after radioiodine therapy. PATIENTS Six women with clinical and biochemical evidence of hyperthyroidism. MEASUREMENTS Serum concentrations of T4, free T3 and osteocalcin, and urinary excretion of the pyridinium cross-links, pyridinaline and deoxypyridinaline, measured before and weekly for 12 weeks after administration of radioiodine. therapy. RESULTS Biochemical indices of bone metabolism were elevated prior to treatment. There was a brisk reduction in circulating thyroid hormones levels paralleled by a similar fall in pyridinium cross-link excretion, which had returned to normal in five patients by the end of the study. There was a positive correlation between pyridinium cross-link excretion and thyroid hormone concentrations. There was no significant change in serum osteocalcin. CONCLUSIONS Treatment of hyperthyroidism results in prompt correction of the associated increased rate of bone collagen degradation suggesting that effective early correction of hyperthyroidism is desirable to limit its detrimental effect on skeletal mass.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 37 条
[1]  
AUWERX J, 1986, Q J MED, V60, P737
[2]   THYROID-HORMONES AND BONE MASS [J].
BARAN, DT ;
BRAVERMAN, LE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06) :1182-1183
[3]   QUANTITATIVE-ANALYSIS OF THE PYRIDINIUM CROSSLINKS OF COLLAGEN IN URINE USING ION-PAIRED REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BLACK, D ;
DUNCAN, A ;
ROBINS, SP .
ANALYTICAL BIOCHEMISTRY, 1988, 169 (01) :197-203
[4]  
COINDRE JM, 1986, ARCH INTERN MED, V146, P48, DOI 10.1001/archinte.146.1.48
[5]   A THERAPEUTIC DILEMMA - SUPPRESSIVE DOSES OF THYROXINE SIGNIFICANTLY REDUCE BONE-MINERAL MEASUREMENTS IN BOTH PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN WITH THYROID-CARCINOMA [J].
DIAMOND, T ;
NERY, L ;
HALES, I .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06) :1184-1188
[6]  
ETTINGER B, 1982, WESTERN J MED, V136, P473
[7]   EXOGENOUS HYPERTHYROIDISM WITH OSTEOPOROSIS [J].
FALLON, MD ;
PERRY, HM ;
BERGFELD, M ;
DROKE, D ;
TEITELBAUM, SL ;
AVIOLI, LV .
ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (03) :442-444
[8]  
FOLIN A, 1965, PRACTICAL PHYSL CHEM, P506
[9]   THYROXINE REPLACEMENT TREATMENT AND OSTEOPOROSIS [J].
FRANKLYN, JA ;
SHEPPARD, MC .
BRITISH MEDICAL JOURNAL, 1990, 300 (6726) :693-694
[10]   SKELETAL INTEGRITY IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN RECEIVING LONG-TERM L-THYROXINE THERAPY [J].
GREENSPAN, SL ;
GREENSPAN, FS ;
RESNICK, NM ;
BLOCK, JE ;
FRIEDLANDER, AL ;
GENANT, HK .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (01) :5-14